XML 41 R24.htm IDEA: XBRL DOCUMENT
v3.21.1

Fair Value Measurements | 3 Months Ended
--- | ---
Apr. 02, 2021
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Note P — Fair Value Measurements Fair value is defined as the price that would be received for an asset or the price that would be paid to transfer a liability in the principal market or most advantageous market in an orderly transaction between market participants at the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs in measuring fair value, and to utilize a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows: •Level 1 — Quoted prices in active markets for identical assets or liabilities. •Level 2 — Observable inputs other than quoted prices included within Level 1, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs other than quoted prices that are observable or are derived principally from, or corroborated by, observable market data by correlation or other means. •Level 3 — Unobservable inputs that are supported by little or no market activity, are significant to the fair value of the assets or liabilities, and reflect our own assumptions about the assumptions market participants would use in pricing the asset or liability developed using the best information available in the circumstances. In certain instances, fair value is estimated using quoted market prices obtained from external pricing services. In obtaining such data from the external pricing services, we have evaluated the methodologies used to develop the estimate of fair value in order to assess whether such valuations are representative of fair value, including net asset value (“NAV”). Additionally, in certain circumstances, the NAV reported by an asset manager may be adjusted when sufficient evidence indicates NAV is not representative of fair value. The following table presents assets and liabilities measured at fair value on a recurring basis (at least annually) at April 2, 2021 and January 1, 2021:
| April 2, 2021 |  | January 1, 2021
(In millions) | Total |  | Level 1 |  | Level 2 |  |  |  | Total |  | Level 1 |  | Level 2 |  |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred compensation plan assets:(1) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity and fixed-income securities | $ | 69 |  |  | $ | 69 |  |  | $ | — |  |  |  |  | $ | 67 |  |  | $ | 67 |  |  | $ | — |  |  |
Investments measured at NAV: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate-owned life insurance | 32 |  |  |  |  |  |  |  |  | 31 |  |  |  |  |  |  |
Total fair value of deferred compensation plan assets | $ | 101 |  |  | $ | 69 |  |  | $ | — |  |  |  |  | $ | 98 |  |  | $ | 67 |  |  | $ | — |  |  |
Derivatives (foreign currency forward contracts) | $ | 21 |  |  | $ | — |  |  | $ | 21 |  |  |  |  | $ | 24 |  |  | $ | — |  |  | $ | 24 |  |  |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Deferred compensation plan liabilities:(2) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity securities and mutual funds | $ | 4 |  |  | $ | 4 |  |  | $ | — |  |  |  |  | $ | 4 |  |  | $ | 4 |  |  | $ | — |  |  |
Investments measured at NAV: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common/collective trusts and guaranteed investment contracts | 124 |  |  |  |  |  |  |  |  | 116 |  |  |  |  |  |  |
Total fair value of deferred compensation plan liabilities | $ | 128 |  |  | $ | 4 |  |  | $ | — |  |  |  |  | $ | 120 |  |  | $ | 4 |  |  | $ | — |  |  |
Derivatives (foreign currency forward contracts) | $ | 2 |  |  | $ | — |  |  | $ | 2 |  |  |  |  | $ | 4 |  |  | $ | — |  |  | $ | 4 |  |  |
_______________ (1)Represents diversified assets held in a “rabbi trust” associated with our non-qualified deferred compensation plans, which we include in the “Other current assets” and “Other non-current assets” line items in our Condensed Consolidated Balance Sheet (Unaudited) and which are measured at fair value. (2)Primarily represents obligations to pay benefits under certain non-qualified deferred compensation plans, which we include in the “Compensation and benefits” and “Other long-term liabilities” line items in our Condensed Consolidated Balance Sheet (Unaudited). Under these plans, participants designate investment options (including stock and fixed-income funds), which serve as the basis for measurement of the notional value of their accounts. The following table presents the carrying amounts and estimated fair values of our significant financial instruments that were not measured at fair value (carrying amounts of other financial instruments not listed in the table below approximate fair value due to the short-term nature of those items):
| April 2, 2021 |  | January 1, 2021
(In millions) | Carrying Amount |  | Fair Value |  | Carrying Amount |  | Fair Value
Long-term debt (including current portion)(1) | $ | 7,078 |  |  | $ | 7,736 |  |  | $ | 6,953 |  |  | $ | 7,986 |
_______________ (1)Fair value was estimated using a market approach based on quoted market prices for our debt traded in the secondary market. If our long-term debt in our balance sheet were measured at fair value, it would be categorized in Level 2 of the fair value hierarchy. See Note B — Business Divestitures and Note J — Goodwill and Other Intangible Assets in these Notes for information regarding fair value measurements associated with goodwill.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration